Disclosed positions

Estimated from their latest filings — positions may have changed since

$1.35M

combined est. value

Stock	Shares	Price	Value	Weight	As of
KMTSKESTRA MEDICAL TECHNOLOGIES, LTD.	40,903	$26.69	$1.09M	81%	2025-09-04
RXSTRxSight, Inc.	35,668	$5.34	$190.5K	14%	2025-07-31
NSPRInspireMD, Inc.	92,417	$0.7425	$68.6K	5%	2026-01-14

KMTS

KESTRA MEDICAL TECHNOLOGIES, LTD.

$1.09M

40,903 sh

RXST

RxSight, Inc.

$190.5K

35,668 sh

NSPR

InspireMD, Inc.

$68.6K

92,417 sh

Activity

Open-market buy & sell volume

BuySell

Total +$289.0K bought

Most bought

KMTS

$289.0K

All filings on record

Every Form 4 transaction we track for this filer

all 5buys 1sells 0

Stock	Transaction	Date	~6mo later
NSPRInspireMD, Inc.	Grant — · 44,030 sh	2026-01-14	—
KMTSKESTRA MEDICAL TECHNOLOGIES, LTD.	Grant — · 10,909 sh	2025-09-04	—
RXSTRxSight, Inc.	Grant — · 35,668 sh	2025-07-31	—
KMTSKESTRA MEDICAL TECHNOLOGIES, LTD.	Grant — · 12,994 sh	2025-07-24	—
KMTSKESTRA MEDICAL TECHNOLOGIES, LTD.	Buy $289.0K · 17,000 sh	2025-03-07	-15.6%

NSPRGrant

2026-01-14 · InspireMD, Inc.

44,030

—

KMTSGrant

2025-09-04 · KESTRA MEDICAL TECHNOLOGIES, LTD.

10,909

—

RXSTGrant

2025-07-31 · RxSight, Inc.

35,668

—

KMTSGrant

2025-07-24 · KESTRA MEDICAL TECHNOLOGIES, LTD.

12,994

—

KMTSBuy

2025-03-07 · KESTRA MEDICAL TECHNOLOGIES, LTD.

$289.0K

-15.6%

Outcomes measure each disclosed buy against the closing price ~6 months (120 trading days) later, with the S&P 500 over the same span for context. Pre-scheduled 10b5-1 plan trades are excluded from the record. Positions are estimated from the latest reported post-transaction holdings, split-adjusted, at the latest close. Built from SEC Form 4 filings and market prices — past outcomes, not predictions or advice.